Pancreatitis from GLP-1 Medications in Virginia
Last Updated: April 1, 2026
Pancreatitis cases linked to GLP-1 medications are being filed by Virginia residents. Virginia is one of the most challenging states for pharmaceutical plaintiffs due to its strict two-year statute of limitations and its status as one of the few states that does NOT recognize the discovery rule for most tort claims. This means the clock typically starts running when the injury occurs, not when it is discovered, making early legal consultation essential. The Eastern District of Virginia, known as the 'Rocket Docket' for its fast case processing, and the Western District provide the federal litigation venues for the state's 8.6 million residents.
Pancreatitis has been linked to GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity. Virginia residents who developed pancreatitis after using these drugs may qualify for compensation. The product liability statute of limitations in Virginia is 2 years. Cases are pending in federal MDL, and attorneys handle claims on a contingency fee basis — no cost unless you win.
Pancreatitis and GLP-1 Medications
Pancreatitis is an inflammation of the pancreas that causes severe, often debilitating abdominal pain. For Virginia residents who developed pancreatitis after using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity, the condition can range from acute episodes requiring emergency hospitalization to chronic pancreatitis causing permanent organ damage. Acute pancreatitis can be life-threatening, with complications including pancreatic necrosis, organ failure, and sepsis. Even patients who recover from acute episodes may face recurring attacks, dietary restrictions, and long-term digestive problems.
The manufacturers of these medications — Novo Nordisk (maker of Ozempic, Wegovy, and Rybelsus) and Eli Lilly (maker of Mounjaro and Trulicity) — are accused of failing to adequately warn patients and prescribing physicians about the risk of pancreatitis. Despite internal data and emerging clinical evidence suggesting a causal link, the drug labels did not include sufficient warnings about the severity and potential permanence of this condition.
For Virginia residents, this means that if you developed pancreatitis while taking a GLP-1 medication, you may have a valid product liability claim. The federal multidistrict litigation (MDL 3094) is consolidating these cases for efficient pretrial proceedings, while preserving each plaintiff's individual right to trial.
Recognizing Pancreatitis from GLP-1 Drugs
If you are a Virginia resident who used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity and experienced any of the following symptoms, you may have developed pancreatitis as a result:
Severe upper abdominal pain
Pain radiating to the back
Nausea and vomiting
Fever
Rapid pulse
Diagnosis
Pancreatitis is typically confirmed through blood tests (lipase/amylase levels) and imaging (ct scan or ultrasound). If you are experiencing symptoms but have not yet received a formal diagnosis, an attorney can help coordinate appropriate medical evaluation as part of your case. Having documented medical evidence strengthens your claim significantly.
Filing a Pancreatitis Claim in Virginia
Virginia residents who developed pancreatitis after using GLP-1 medications have specific legal options and deadlines. The statute of limitations for product liability claims in Virginia is 2 years, and the personal injury statute of limitations is 2 years.
Virginia has limited application of the discovery rule in product liability cases. This means that filing deadlines may be calculated more strictly than in other states, and delays in seeking legal counsel could jeopardize your ability to file a claim. It is especially important for Virginia residents to act promptly.
Cases may be filed in the Virginia Circuit Courts at the state level or in federal court through the Eastern District of Virginia (or other Virginia federal districts). Most GLP-1 injury cases are being coordinated through the federal MDL for pretrial proceedings.
Virginia legal landscape: Virginia is one of the few states that still applies contributory negligence as a complete bar to recovery. The state does not recognize strict liability for product defect claims — plaintiffs must proceed under negligence or breach of warranty theories. These rules make Virginia one of the most defense-friendly jurisdictions for pharmaceutical litigation. Residents in Virginia Beach, Norfolk, Richmond, Arlington, and Chesapeake and surrounding areas should consult with an attorney to evaluate their potential pancreatitis claim.
Personal Injury SOL
2 years
Product Liability SOL
2 years
Discovery Rule
Limited
GLP-1 Drugs Linked to Pancreatitis
The following GLP-1 receptor agonist medications have been linked to pancreatitis in ongoing litigation. If you used any of these drugs in Virginia and developed pancreatitis, you may qualify for a claim:
Ozempic
Semaglutide injection by Novo Nordisk. Prescribed for type 2 diabetes.
Wegovy
Semaglutide injection by Novo Nordisk. Prescribed for weight management.
Mounjaro
Tirzepatide injection by Eli Lilly. Prescribed for type 2 diabetes and weight management.
Rybelsus
Oral semaglutide by Novo Nordisk. Prescribed for type 2 diabetes.
Saxenda
Liraglutide injection by Novo Nordisk. Prescribed for weight management.
Trulicity
Dulaglutide injection by Eli Lilly. Prescribed for type 2 diabetes.
Do You Qualify for a Pancreatitis Claim in Virginia?
Virginia residents may be eligible to file a pancreatitis claim if the following criteria apply:
Used a GLP-1 Medication
You were prescribed and used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity or another GLP-1 receptor agonist medication.
Diagnosed with Pancreatitis
You received a medical diagnosis of pancreatitis through blood tests (lipase/amylase levels) and imaging (ct scan or ultrasound).
Injury Occurred After Drug Use
Your pancreatitis developed after you began taking the GLP-1 medication, establishing a timeline consistent with causation.
Within Virginia's Filing Deadline
Your claim falls within Virginia's product liability statute of limitations (2 years). An attorney can evaluate your specific timeline.
Pancreatitis in Virginia: FAQ
What is pancreatitis and how is it linked to GLP-1 medications in Virginia?
Inflammation of the pancreas causing severe abdominal pain. GLP-1 medications including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity have been linked to an increased risk of developing this condition. Virginia residents who were prescribed these medications and subsequently developed pancreatitis may be eligible to file a lawsuit seeking compensation for their injuries, medical expenses, and other damages.
What are the symptoms of pancreatitis caused by Ozempic or other GLP-1 drugs?
Common symptoms of pancreatitis include severe upper abdominal pain, pain radiating to the back, nausea and vomiting, fever, rapid pulse. If you experienced these symptoms after taking Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity in Virginia, you should seek medical attention immediately and consider having your case evaluated for potential legal action.
How is pancreatitis diagnosed for purposes of a GLP-1 lawsuit?
Pancreatitis is typically diagnosed through blood tests (lipase/amylase levels) and imaging (ct scan or ultrasound). For Virginia residents filing a GLP-1 injury claim, medical documentation confirming your diagnosis is important for establishing your case. If you have not yet been formally diagnosed but are experiencing symptoms, your attorney can help coordinate appropriate medical evaluation.
What is the statute of limitations for a pancreatitis claim in Virginia?
In Virginia, the statute of limitations for product liability claims is 2 years. Virginia has limited discovery rule application, so prompt action is especially important. Consult with an attorney to determine your exact deadline.
What compensation can I receive for pancreatitis caused by GLP-1 drugs in Virginia?
Virginia residents who qualify may recover compensation for medical expenses (including emergency treatment, surgery, hospitalization, and rehabilitation), lost wages, pain and suffering, emotional distress, and diminished quality of life. The amount depends on the severity of your pancreatitis and its impact on your daily life.
Is there any cost to file a pancreatitis claim in Virginia?
There is no upfront cost. Attorneys handling GLP-1 pancreatitis cases in Virginia work on a contingency fee basis, meaning they only receive payment if you receive compensation through settlement or trial verdict. NuLegal's initial case review is completely free with no obligation.
Related Resources
Other GLP-1 Injuries in Virginia
Virginia Residents: Get Your Free Case Review
If you developed pancreatitis after using Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Trulicity, time may be limited. Virginia's product liability statute of limitations is 2 years. Get a free, no-obligation evaluation today.
Free Case ReviewAdvertisement
Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.